Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells.

[1]  S. Nagataki,et al.  Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis. , 1996, The Journal of rheumatology.

[2]  S. Nagataki,et al.  Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast‐like cells , 1996, Clinical and experimental immunology.

[3]  S. Nagataki,et al.  Increase in adhesion molecules on CD4+ cells and CD4+ cell subsets in synovial fluid from patients with rheumatoid arthritis. , 1994, The Journal of rheumatology.

[4]  G. Zlabinger,et al.  Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. , 1994, Journal of immunology.

[5]  S. Nagataki,et al.  Immunolocalization of Adhesion Molecules in Rheumatoid and Osteoarthritic Synovial Tissues , 1993 .

[6]  G. Panayi,et al.  Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. , 1993, Annals of the rheumatic diseases.

[7]  J. Gribben,et al.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. , 1993, Science.

[8]  L. Lanier,et al.  B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.

[9]  K. Tanaka,et al.  Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6. , 1992, Journal of pharmacobio-dynamics.

[10]  R. Kitamura,et al.  Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 3rd communication: the involvement of bradykinin in its analgesic actions. , 1992, Journal of pharmacobio-dynamics.

[11]  K. Eguchi,et al.  Bucillamine inhibits T cell adhesion to human endothelial cells. , 1992, The Journal of rheumatology.

[12]  P. Linsley,et al.  Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. , 1992, Journal of immunology.

[13]  K. Matsushima,et al.  Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. , 1991, Lymphokine and cytokine research.

[14]  K. Eguchi,et al.  Phenotypic characteristics of T cells interacted with synovial cells. , 1991, The Journal of rheumatology.

[15]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[16]  E. Clark,et al.  The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells , 1991, The Journal of experimental medicine.

[17]  L. Davis,et al.  Accessory Cell Signals Involved in T‐Cell Activation , 1990, Immunological reviews.

[18]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[19]  F. Epstein,et al.  Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.

[20]  T. Rème,et al.  T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Phenotyping of multiple synovial sites. , 1990, Arthritis and rheumatism.

[21]  J. Dayer,et al.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[22]  K. Migita,et al.  Phenotypic characterization of lymphocytes infiltrating synovial tissue from patients with rheumatoid arthritis: analysis of lymphocytes isolated from minced synovial tissue by dual immunofluorescent staining. , 1990, The Journal of rheumatology.

[23]  P. Scuderi,et al.  Characteristics of tumor necrosis factor production in rheumatoid arthritis. , 1989, Cellular immunology.

[24]  T. Hirano,et al.  Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. , 1989, Clinical immunology and immunopathology.

[25]  G. Firestein,et al.  Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. , 1989, The Journal of clinical investigation.

[26]  P. Guerne,et al.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. , 1989, The Journal of clinical investigation.

[27]  T. Hirano,et al.  Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis , 1988, European journal of immunology.

[28]  F. Houssiau,et al.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. , 1988, Arthritis and rheumatism.

[29]  N. Miyasaka,et al.  Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. , 1988, Arthritis and rheumatism.

[30]  M. Vadas,et al.  The detection and initial characterization of colony-stimulating factors in synovial fluid. , 1988, Clinical and experimental immunology.

[31]  Keiichi Tanaka,et al.  Pharmacological studies on T-614, a novel antiinflammatory agent: effect on type II collagen-induced arthritis in DBA/1J mice and spontaneous arthritis in MRL/I mice , 1993 .

[32]  J. Nunley,et al.  Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. , 1989, Arthritis and rheumatism.